Search

Current filters: Treatment, Hepatitis C drugs, Hepatitis C

Zepatier (elbasvir + grazoprevir)

2019, CATIE
Fact sheet - Webpage

The Hep C Revolution

From The Positive Side - Fall 2016
2016, CATIE
Client resources - Webpage

Epclusa (velpatasvir + sofosbuvir)

2020, CATIE
Fact sheet - Webpage

Sofosbuvir + velpatasvir – improvements in quality of life, energy and emotional and mental health

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Sofosbuvir + velpatasvir – interactions with other medicines

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Sofosbuvir + velpatasvir in HIV co-infection

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Sofosbuvir + velpatasvir (Epclusa) + ribavirin for retreatment

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Large review from three French studies finds no link between use of DAAs and recurrence of liver cancer

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Bologna researchers find no link between DAAs and liver cancer

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Vienna doctors urge caution when assessing possible associations between liver cancer recurrence and use of DAAs

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage